siRNA Targeting and Treatment of Gastrointestinal Diseases
RNA interference via small interfering RNA (siRNA) offers opportunities to precisely target genes that contribute to gastrointestinal (GI) pathologies, such as inflammatory bowel disease, celiac, and esophageal scarring. Delivering the siRNA to the GI tract proves challenging as the harsh environmen...
Saved in:
Main Author: | Rachel Chevalier (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fate of Tableted Freeze-Dried siRNA Lipoplexes in Gastrointestinal Environment
by: Asad Ur Rehman, et al.
Published: (2021) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
siRNA goes after diseases of the bone
by: Andrew H. Coles
Published: (2023) -
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
by: Borja Ballarín-González, et al.
Published: (2013)